John J. Orloff - Jun 8, 2021 Form 4 Insider Report for ALEXION PHARMACEUTICALS, INC. (ALXN)

Role
EVP, Research & Development
Signature
/s/ Douglas Barry, Attorney-in-Fact for John Orloff
Stock symbol
ALXN
Transactions as of
Jun 8, 2021
Transactions value $
-$346,389
Form type
4
Date filed
6/9/2021, 04:53 PM
Next filing
Jul 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXN Common Stock, par value $.0001 per share Tax liability -$346K -1.96K -2.22% $177.00 86.4K Jun 8, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.